Draculin
Latest Information Update: 03 Jul 2002
At a glance
- Originator Aventis; Venezuelan Institute for Scientific Research
- Developer Venezuelan Institute for Scientific Research
- Class Anticoagulants
- Mechanism of Action Factor IXa inhibitors; Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis